| Ticker Details |
|
Athira Pharma, Inc.
|
| IPO Date: |
September 18, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$26.62M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.24 | 3.43%
|
| Avg Daily Range (30 D): |
$0.54 | 7.40%
|
| Avg Daily Range (90 D): |
$0.25 | 3.94%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.18M |
| Avg Daily Volume (30 D): |
M |
| Avg Daily Volume (90 D): |
.66M |
| Trade Size |
| Avg Trade Size (Sh.): |
61 |
| Avg Trade Size (Sh.) (30 D): |
123 |
| Avg Trade Size (Sh.) (90 D): |
94 |
| Institutional Trades |
| Total Institutional Trades: |
149 |
| Avg Institutional Trade: |
$1.76M |
| Avg Institutional Trade (30 D): |
$.75M |
| Avg Institutional Trade (90 D): |
$.75M |
| Avg Institutional Trade Volume: |
.02M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.81M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
22.26K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-24.7
|
$-18.9
|
$-24.7
|
|
Diluted EPS
|
$-24.7
|
$-18.9
|
$-24.7
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-105.61M
|
$-82.89M
|
$-105.61M
|
|
Operating Income / Loss
|
$-102.27M
|
$-78.57M
|
$-102.27M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-45.7M
|
$-19.4M
|
$-45.7M
|
|
PE Ratio
|
|
|
|
|
|
|